All-trans retinoic acid shifts propionibacterium acnes-induced matrix degradation expression profile toward matrix preservation in human monocytes

Journal of Investigative Dermatology

Volumn 128, Issue 12, 2008, Pages 2777-2782

  Jalian, H Ray ^a   Liu, Philip T ^a   Kanchanapoomi, Melissa ^a   Phan, Jenny N ^a   Legaspi, Annaliza J ^a   Kim, Jenny ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; INTERSTITIAL COLLAGENASE; RETINOIC ACID; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TOLL LIKE RECEPTOR 2;

ACNE; ARTICLE; CELL INFILTRATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOCYTE; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; PROTEIN EXPRESSION;

GENE EXPRESSION REGULATION, BACTERIAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; IMMUNE SYSTEM; MODELS, BIOLOGICAL; MONOCYTES; PHENOTYPE; PROPIONIBACTERIUM ACNES; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TOLL-LIKE RECEPTORS; TRETINOIN;

EID: 57349108590     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2008.155     Document Type: Article

References (31)

1. Abraham M, Shapiro S, Lahat N, Miller A (2002) The role of IL-18 and IL-12 in the modulation of matrix metalloproteinases and their tissue inhibitors in monocytic cells. Int Immunol 14:1449-57
2. Birkedal-Hansen H (1995) Matrix metalloproteinases. Adv Dent Res 9(3 Suppl):16
3. Brightbill HD, Libraty DH, Krutzik SR, Yang RB, Belisle JT, Bleharski JR et al (1999) Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285:732-6
4. Burrage PS, Mix KS, Brinckerhoff CE (2006) Matrix metalloproteinases: role in arthritis. Front Biosci 11:529-43
5. Webster NL, Crowe SM (2006) Matrix metalloproteinases, their production by monocytes and macrophages and their potential role in HIV-related diseases. J Leukoc Biol 80:1052-66
6. Dedieu S, Lefebvre P (2006) Retinoids interfere with the AP1 signalling pathway in human breast cancer cells. Cell Signal 18:889-98
7. Elass E, Aubry L, Masson M, Denys A, Guerardel Y, Maes E et al (2005) Mycobacterial lipomannan induces matrix metalloproteinase-9 expression in human macrophagic cells through a Toll-like receptor 1 (TLR1). Infect Immun 73:7064-8
8. Elkington PT, Emerson JE, Lopez-Pascua LD, O''Kane CM, Horncastle DE, Boyle JJ et al (2005) Mycobacterium tuberculosis up-regulates matrix metalloproteinase-1 secretion from human airway epithelial cells via a p38 MAPK switch. J Immunol 175:5333-40
9. Fisher GJ, Talwar HS, Lin J, Lin P, McPhillips F, Wang Z et al (1998) Retinoic acid inhibits induction of c-Jun protein by ultraviolet radiation that occurs subsequent to activation of mitogen-activated protein kinase pathways in human skin in vivo. J Clin Invest 101:1432-40
10. Gebbia JA, Coleman JL, Benach JL (2004) Selective induction of matrix metalloproteinases by Borrelia burgdorferi via toll-like receptor 2 in monocytes. J Infect Dis 189:113-9
11. Ho LJ, Lin LC, Hung LF, Wang SJ, Lee CH, Chang DM et al (2005) Retinoic acid blocks pro-inflammatory cytokine-induced matrix metalloproteinase production by down-regulating JNK-AP-1 signaling in human chondrocytes. Biochem Pharmacol 70:200-8
12. Hu LT, Eskildsen MA, Masgala C, Steere AC, Arner EC, Pratta MA et al (2001) Host metalloproteinases in Lyme arthritis. Arthritis Rheum 44:1401-10
13. Janssen de Limpens AM (1980) The local treatment of hypertrophic scars and keloids with topical retinoic acid. Br J Dermatol 103:319-23
14. Kang S, Cho S, Chung JH, Hammerberg C, Fisher GJ, Voorhees JJ (2005) Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor-kappaB and activator protein-1 in inflammatory acne lesions in vivo. Am J Pathol 166:1691-9
15. Kim J, Ochoa MT, Krutzik SR, Takeuchi O, Uematsu S, Legaspi AJ et al (2002) Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol 169:1535-41
16. Kyburz D, Rethage J, Seibl R, Lauener R, Gay RE, Carson DA et al (2003) Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by toll-like receptor signaling. Arthritis Rheum 48:642-50
17. Layton AM (2001) Optimal management of acne to prevent scarring and psychological sequelae. Am J Clin Dermatol 2:135-41
18. Liu PT, Krutzik SR, Kim J, Modlin RL (2005) Cutting edge: all-trans retinoic acid down-regulates TLR2 expression and function. J Immunol 174:2467-70
19. Lobmann R, Ambrosch A, Schultz G, Waldmann K, Schiweck S, Lehnert HM (2002) Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 45:1011-6
20. Mizutani H, Yoshida T, Nouchi N, Hamanaka H, Shimizu M (1999) Topical tocoretinate improved hypertrophic scar, skin sclerosis in systemic sclerosis and morphea. J Dermatol 26:11-7
21. Monney L, Sabatos CA, Gaglia JL, Ryu A, Waldner H, Chernova T et al (2002) Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415:536-41
22. Narbutt J, Waszczykowska E, Lukamowicz J, Sysa-Jedrzejowska A, Kobos J, Zebrowska A (2006) Disturbances of the expression of metalloproteinases and their tissue inhibitors cause destruction of the basement membrane in pemphigoid. Pol J Pathol 57:71-6
23. Papakonstantinou E, Aletras AJ, Glass E, Tsogas P, Dionyssopoulos A, Adjaye J et al (2005) Matrix metalloproteinases of epithelial origin in facial sebum of patients with acne and their regulation by isotretinoin. J Invest Dermatol 125:673-84
24. Saarialho-Kere UK (1998) Patterns of matrix metalloproteinase and TIMP expression in chronic ulcers. Arch Dermatol Res 290:S47-54
25. Sapadin AN, Fleischmajer R (2006) Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol 54:258-65
26. Schmidt JB, Donath P, Hannes J, Perl S, Neumayer R, Reiner A (1999) Tretinoin-iontophoresis in atrophic acne scars. Int J Dermatol 38:149-53
27. Tayebjee MH, Lip GY, Tan KT, Patel JV, Hughes EA, MacFadyen RJ (2005) Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease. Am J Cardiol 96:339-45
28. Trivedi NR, Gilliland KL, Zhao W, Liu W, Thiboutot DM (2006) Gene array expression profiling in acne lesions reveals marked upregulation of genes involved in inflammation and matrix remodeling. J Invest Dermatol 126:1071-9
29. Tsang KJ, Crowe DL (2001) Retinoic acid and extracellular matrix inhibition of matrix metalloproteinase 9 expression is mediated by the mitogen activated protein kinase pathway. Int J Oncol 18:369-74
30. Vaalamo M, Leivo T, Saarialho-Kere U (1999) Differential expression of tissue inhibitors of metalloproteinases (TIMP-1, -2, -3, and -4) in normal and aberrant wound healing. Hum Pathol 30:795-802
31. Vowels BR, Yang S, Leyden JJ (1995) Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne. Infect Immun 63:3158-65